Boston Scientific Corporation (NYSE:BSX) caught in the “mesh” of a lawsuit

Posted by Lynn Eisler June 21, 2013 0 Comment 1772 views

Parker Waichman LLP is a law firm that is dedicated to protection of the rights of victims who have been injured by medical devices and dangerous drugs. It filed a lawsuit on behalf of an Arizona-based woman. The allegation is that she has been injured by the transvaginal mesh products she used. The two products, Pinnacle Pelvic Floor Repair Kit manufactured by Boston Scientific Corporation (NYSE:BSX) and the MiniArc Sling manufactured by American medical Systems are the two devices in question. The plaintiff has also alleged that both the defendants were aware of the defects of their respective products and that they failed to warn consumers about the defects.

What is a transvaginal mesh?

The transvaginal mesh was launched in the 1990s. At that time it was meant to be a permanent fix for pelvic organ prolapse as well as stress urinary incontinence. Generally, older women suffer from these conditions, post menopause or a hysterectomy. However, there are numerous known complications that can arise from the use of a transvaginal mesh, organ erosion and perforation being some of them. Less-severe issues such as urinary incontinence and constipation may also result.

In 2008, the Food Drug Administration had issued one public health notification that revealed the serious complications of a transvaginal mesh. However, they said that the occurrences were not too common. In 2011, the advisory was updated by the FDA and said that serious complications from this product were not a rarity. Mesh manufacturers were instructed to conduct some post-market safety studies.

What is mesh erosion?

Also known as a mesh extrusion, transvaginal mesh erosion is a common problem that is associated with such implants. When irregular edges of this synthetic mesh, cut through or erode the vaginal lining as well as the nearby organs. This leads to organ perforation, bleeding, infection and urinary problems amongst other things. The FDA reviewed published scientific research between 1996 and 2011 and found that using mesh repairs to fix pelvic prolapse may not really get rid of prolapse symptoms or improve the quality of the patient life any more than non-mesh repairs can. Its going to take Boston Scientific Corporation (NYSE:BSX) some squirming to get out of this one.

About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment